A randomised controlled trial investigating ventilation imaging to improve the quality of life for patients with lung cancer treated with radiation therapy VITaL

This trial is testing a new treatment planning method for patients with lung cancer who will be treated with radiation therapy. This new method is called Computed Tomography (CT) ventilation imaging. It aims to help protect the healthiest parts of patient's lungs from being injured by the radiation therapy. The investigators will determine whether healthy lung sparing can improve the quality of life in these patients.


For more information about VITaL visit: https://image-x.sydney.edu.au/the-vital-clinical-trial/

Primary Sponsor

The University of Sydney

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Accrual Target

165

Trial Chairperson

Prof Paul Keall, Image X Institute, NSW, Australia

Trial Contact

qa@trog.com.au

Clinical Trial Registration

Related Post

RTQA review paper
14 May, 2026

Review highlights vital need for RTQA in radiation therapy research

LATEST NEWS: 14 May 2026 The need for greater

14 April, 2026

Consumer Engagement Charter cements TROG’s commitment to listen to consumer voices

LATEST NEWS: 14 April 2026 TROG has made a